Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

47,962 studies found

Recruiting
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leuke...

Conditions: AML, RUNX1-RUNX1T1 Fusion Protein Expression

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)

Conditions: AL Amyloidosis

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.

Conditions: Autoimmune Hemolytic Anemia (AIHA)

Institute of Hematology & Blood Diseases Hospital Tianj...

View details
Recruiting
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrenc...

Conditions: HCC - Hepatocellular Carcinoma

Tianjin Medical University Cancer Institute & Hospital...

View details
Not Yet Recruiting
To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With N...

Conditions: Locally Advanced Rectal Cancer (LARC)

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)

Tianjin Medical University Cancer Insititute & Hospital...

View details
Active Not Recruiting
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Conditions: Resectable Non-small Cell Lung Cancer

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

Conditions: Biliary Tract Cancer (BTC)

Department of Radiation Oncology, Tianjin Medical Unive...

View details
Recruiting
HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Conditions: Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)

Institute of Hematology and Blood Diseases Hospital, Ti...

View details
Recruiting
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

Conditions: High Risk Smoldering Multiple Myeloma

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Conditions: Systemic Light Chain Amyloidosis

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Not Yet Recruiting
Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Eso...

Conditions: Esophageal Squamous Cell Carcinoma (ESCC)

Department of minimally invasive esophageal surgery, Ti...

View details
Not Yet Recruiting
A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treat...

Conditions: Factor VII Deficiency

Institute of Hematology & Blood Diseases Hospital, Chin...

View details
Recruiting
Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With...

Conditions: Advanced Refractory Solid Tumors, EGFR Gene Overexpression

Tianjin Medical Unversity Second Hospital Tianjin Tianj...

View details
Recruiting
Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced...

Conditions: Hypopharyngeal Squamous Cell Carcinoma

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
A Single-Arm Clinical Trial of Percutaneous Splenic Ablation Combined With Splenic Artery Occlu...

Conditions: Secondary Hypersplenism

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therap...

Conditions: Neoadjuvant Immunotherapy

The Second Hospital of Tianjin Medical University Tianj...

View details
Active Not Recruiting
Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal...

Conditions: Renal Cell Carcinoma, Kidney Neoplasms, Endophytic Renal Tumor, Postoperative Re...

Tianjin Medical University Second Hospital Tianjin Tian...

View details
Recruiting
Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumor...

Conditions: Thymic Epithelial Tumor

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuv...

Conditions: Pancreatic Cancer, Adult

Tianjin Medical University Cancer Institute and Hospita...

View details
Not Yet Recruiting
SYH2095 for Advanced Malignant Tumors: Phase I Study

Conditions: Advanced Malignant Tumors

Tianjin Medical University Cancer Institute and Hospita...

View details
Not Yet Recruiting
META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia (AIHA)

Blood Diseases Hospital, Chinese Academy of Medical Sci...

View details
Not Yet Recruiting
Acupuncture for Heel Pain Syndrome

Conditions: Heel Pain Syndrome

The First Teaching Hospital of Tianjin University of Tr...

View details
Not Yet Recruiting
Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

Conditions: Immune Thrombocytopenia

Ethics Committee of Blood disease hospital, Chinese Aca...

View details